Green Cross Cash Flow Conversion Efficiency
Green Cross cash flow conversion efficiency. Based on the latest financial reports, Green Cross (005250) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.95 Billion ≈ $94.84 Million USD) by net assets (₩1.89 Trillion ≈ $1.28 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Green Cross (2000–2024)
Cash flow conversion efficiency of Green Cross from 2000 to 2024. This chart illustrates how Green Cross's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Green Cross share price for real-time trading data and today's change.
Green Cross Cash Flow Conversion Ratio Explained
Green Cross cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Green Cross Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Green Cross ranked by their cash flow conversion efficiency. Also see 005250 market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Yuxing Film Tech
SHE:300305
|
-0.016x |
|
Instone Real Estate Group AG
XETRA:INS
|
-0.012x |
|
Accent Group Ltd
AU:AX1
|
0.226x |
|
J.Jill Inc
NYSE:JILL
|
0.014x |
|
Kingstone Companies Inc
NASDAQ:KINS
|
0.000x |
|
Dadelo S.A.
WAR:DAD
|
0.186x |
|
Asflow Co. Ltd.
KQ:159010
|
-0.025x |
|
Horizon Technology Finance
NASDAQ:HRZN
|
0.029x |
Annual Cash Flow Conversion Efficiency for Green Cross (2000–2024)
The table below shows the annual cash flow conversion efficiency of Green Cross from 2000 to 2024. Review Green Cross free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.85 Trillion ≈ $1.26 Billion |
₩-89.95 Billion ≈ $-60.96 Million |
-0.049x | -130.42% |
| 2023-12-31 | ₩1.88 Trillion ≈ $1.28 Billion |
₩-39.65 Billion ≈ $-26.87 Million |
-0.021x | -142.67% |
| 2022-12-31 | ₩1.97 Trillion ≈ $1.33 Billion |
₩97.16 Billion ≈ $65.84 Million |
0.049x | -9.05% |
| 2021-12-31 | ₩1.91 Trillion ≈ $1.29 Billion |
₩103.77 Billion ≈ $70.32 Million |
0.054x | +154.07% |
| 2020-12-31 | ₩1.67 Trillion ≈ $1.13 Billion |
₩35.77 Billion ≈ $24.24 Million |
0.021x | +320.95% |
| 2019-12-31 | ₩1.51 Trillion ≈ $1.02 Billion |
₩7.65 Billion ≈ $5.18 Million |
0.005x | -80.40% |
| 2018-12-31 | ₩1.45 Trillion ≈ $984.76 Million |
₩37.64 Billion ≈ $25.51 Million |
0.026x | -74.19% |
| 2017-12-31 | ₩1.44 Trillion ≈ $975.64 Million |
₩144.48 Billion ≈ $97.91 Million |
0.100x | +17256.99% |
| 2016-12-31 | ₩1.38 Trillion ≈ $933.18 Million |
₩-805.47 Million ≈ $-545.86K |
-0.001x | -110.87% |
| 2015-12-31 | ₩1.31 Trillion ≈ $885.99 Million |
₩7.04 Billion ≈ $4.77 Million |
0.005x | -88.35% |
| 2014-12-31 | ₩1.18 Trillion ≈ $800.39 Million |
₩54.54 Billion ≈ $36.96 Million |
0.046x | +189.06% |
| 2013-12-31 | ₩1.10 Trillion ≈ $745.23 Million |
₩17.57 Billion ≈ $11.91 Million |
0.016x | -57.76% |
| 2012-12-31 | ₩972.83 Billion ≈ $659.27 Million |
₩36.80 Billion ≈ $24.94 Million |
0.038x | -70.84% |
| 2011-12-31 | ₩895.76 Billion ≈ $607.04 Million |
₩116.18 Billion ≈ $78.73 Million |
0.130x | -69.37% |
| 2010-12-31 | ₩839.83 Billion ≈ $569.14 Million |
₩355.62 Billion ≈ $241.00 Million |
0.423x | -54.13% |
| 2009-12-31 | ₩522.78 Billion ≈ $354.28 Million |
₩482.60 Billion ≈ $327.05 Million |
0.923x | +93.20% |
| 2008-12-31 | ₩350.47 Billion ≈ $237.51 Million |
₩167.47 Billion ≈ $113.49 Million |
0.478x | -36.16% |
| 2007-12-31 | ₩351.08 Billion ≈ $237.92 Million |
₩262.77 Billion ≈ $178.07 Million |
0.748x | +59.53% |
| 2006-12-31 | ₩221.73 Billion ≈ $150.26 Million |
₩104.03 Billion ≈ $70.50 Million |
0.469x | +78.48% |
| 2005-12-31 | ₩236.96 Billion ≈ $160.59 Million |
₩62.29 Billion ≈ $42.22 Million |
0.263x | -69.80% |
| 2003-12-31 | ₩210.22 Billion ≈ $142.46 Million |
₩182.96 Billion ≈ $123.99 Million |
0.870x | +648.32% |
| 2001-12-31 | ₩273.93 Billion ≈ $185.64 Million |
₩31.86 Billion ≈ $21.59 Million |
0.116x | -39.13% |
| 2000-12-31 | ₩282.15 Billion ≈ $191.21 Million |
₩53.91 Billion ≈ $36.53 Million |
0.191x | -- |
About Green Cross
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more